New Nanomaterial Shows Promise in Eliminating Cancer Cells Without Harming Healthy Tissue
Researchers have developed an innovative nanomaterial capable of selectively targeting and destroying cancer cells whereas leaving healthy tissues unharmed, according to a recent study. This breakthrough offers a potential new approach to cancer treatment, minimizing the debilitating side effects often associated with traditional therapies.
The study, detailed in findings released on December 27, 2023, by Russian scientists from the Moscow Institute of Physics and Technology, sheds light on the mechanisms by which cancer cells impact surrounding healthy tissues. Understanding these interactions is crucial for developing more effective and targeted treatments.
Separately, a study published on October 23, 2025, identified a protein, “folate receptor beta,” that appears extensively in solid tumors in children and adolescents. This discovery could significantly improve surgical precision in removing cancerous tissue. Researchers found that targeting these receptors with a fluorescent imaging agent called “pafolacianine” helps surgeons better distinguish between cancerous and healthy cells during operations. The research, conducted by teams at Ann & Robert H. Lurie Children’s Hospital and Feinberg School of Medicine at Northwestern University, was published in the journal Oncotarget on October 16, 2025.
Removing childhood cancers completely during surgery can be challenging, particularly when tumors have spread or formed small deposits. The ability to accurately identify and remove all cancerous tissue is vital for improving patient outcomes.
Another recent discovery, reported by MSN on March 8, 2026, details a nanomaterial that exploits the chemical composition of cancer itself to selectively eliminate malignant cells. This approach represents a significant step forward in the development of targeted cancer therapies.
